ID221 Bortezomib for the treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis

• Asıl Yazarlar: Vania dos Santos Nunes Nogueira (Yazar), Lucas Oliveira Cantadori (Yazar), Mariana Andrades Fiorini Monteiro Novo (Yazar), Fernanda Minicucci (Yazar), Rafael Dezen Gaiolla (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia, 2024-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Introduction Multiple myeloma (MM) is an incurable malignant neoplasm that accounts for approximately 1% of all cancers and 10% of hematological malignancies. Bortezomib is one of the most commonly used medications in first-line treatment and subsequent relapses, either as a single agent or in combi...